Stocktoria
AtriCure, Inc. ATRC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2005-08-05
AtriCure, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $534.5M | $465.3M | $399.2M | $330.4M | $274.3M |
| Gross profit | $400.8M | $347.5M | $300.4M | $245.9M | $205.9M |
| R&D expense | $99.2M | $96.2M | $73.9M | $57.3M | $48.5M |
| SG&A expense | $311.0M | $291.4M | $253.1M | $231.3M | $204.6M |
| Operating income | -$9.4M | -$40.0M | -$26.7M | -$42.7M | $55.2M |
| Interest expense | — | — | $6.9M | $5.0M | $4.9M |
| Income tax | $1.3M | $1.0M | $591,000 | $268,000 | $188,000 |
| Net income | -$11.4M | -$44.7M | -$30.4M | -$46.5M | $50.2M |
| EPS (diluted) | $-0.24 | $-0.95 | $-0.66 | $-1.02 | $1.09 |
| Operating cash flow | $57.3M | $12.2M | $4.5M | -$22.1M | -$13.8M |
| Free cash flow | $48.3M | $745,000 | -$7.5M | -$39.0M | -$23.5M |
| Cash & equivalents | $167.4M | $122.7M | $84.3M | $58.1M | $43.7M |
| Inventory | $78.5M | $75.3M | $67.9M | $45.9M | $39.0M |
| Total assets | $654.2M | $609.3M | $613.9M | $585.4M | $615.3M |
| Total liabilities | $162.2M | $148.4M | $147.8M | $128.7M | $131.6M |
| Shareholders' equity | $491.9M | $461.0M | $466.2M | $456.8M | $483.8M |
Source: SEC EDGAR filings · CIK 0001323885 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.